Drug-Eluting versus Bare-Metal Stents in Large Coronary Arteries

Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing

1995 • 93,704 citations

Categorical Data Analysis

2002 • 6,038 citations

Clinical End Points in Coronary Stent Trials

2007 • 5,164 citations

Myocardial infarction redefined—A consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction

2000 • 2,092 citations

Late Clinical Events After Clopidogrel Discontinuation May Limit the Benefit of Drug-Eluting Stents

2006 • 1,316 citations

Everolimus-Eluting versus Paclitaxel-Eluting Stents in Coronary Artery Disease

2010 • 871 citations

Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial

2010 • 678 citations

Sirolimus-Eluting and Paclitaxel-Eluting Stents for Coronary Revascularization

2005 • 608 citations

Comparison of an Everolimus-Eluting Stent and a Paclitaxel-Eluting Stent in Patients With Coronary Artery Disease

2008 • 580 citations

Vessel Size and Long-Term Outcome After Coronary Stent Placement

1998 • 484 citations

Coronary Stents

2010 • 482 citations

Effectiveness and Safety of Drug-Eluting Stents in Ontario

2007 • 398 citations

Sirolimus-Eluting vs Uncoated Stents for Prevention of Restenosis in Small Coronary Arteries

2004 • 321 citations

A Comparison of the Clinical Impact of Bleeding Measured by Two Different Classifications Among Patients With Acute Coronary Syndromes

2006 • 302 citations

Stent Thrombosis Redux — The FDA Perspective

2007 • 287 citations

Angiographic and clinical outcome following coronary stenting of small vessels

1998 • 285 citations

A Randomized Comparison of the Endeavor Zotarolimus-Eluting Stent Versus the TAXUS Paclitaxel-Eluting Stent in De Novo Native Coronary Lesions

2010 • 241 citations

Long-Term Safety and Efficacy of Drug-Eluting versus Bare-Metal Stents in Sweden

2009 • 238 citations

Long-Term Clinical and Angiographic Follow-Up After Coronary Stent Placement in Native Coronary Arteries

2002 • 203 citations

A Randomized Trial Comparing Stenting With Balloon Angioplasty in Small Vessels in Patients With Symptomatic Coronary Artery Disease

2000 • 179 citations

Long-term benefit-risk balance of drug-eluting vs. bare-metal stents in daily practice: does stent diameter matter? Three-year follow-up of BASKET

2008 • 106 citations

Randomized comparison of coronary stenting with optimal balloon angioplasty for treatment of lesions in small coronary arteries

2000 • 104 citations

Coronary stenting versus balloon angioplasty in small vessels

2004 • 101 citations

Targeted stent use in clinical practice based on evidence from the BAsel Stent Cost Effectiveness Trial (BASKET)

2007 • 77 citations

Comparison of Effectiveness of Bare Metal Stents Versus Drug-Eluting Stents in Large (≥3.5 mm) Coronary Arteries

2007 • 58 citations

Impact of Vessel Size on Angiographic and Clinical Outcomes of Revascularization With Biolimus-Eluting Stent With Biodegradable Polymer and Sirolimus-Eluting Stent With Durable Polymer

2009 • 51 citations

An everolimus‐eluting stent versus a paclitaxel‐eluting stent in small vessel coronary artery disease: A pooled analysis from the SPIRIT II and SPIRIT III trials

2010 • 40 citations

Clinical and angiographic comparison of everolimus-eluting and paclitaxel-eluting stents in small coronary arteries: A post hoc analysis of the SPIRIT III randomized trial

2009 • 38 citations

Drug-eluting or bare-metal stents for large coronary vessel stenting? The BASKET-PROVE (PROspective Validation Examination) trial: Study protocol and design

2008 • 28 citations

FDA panel, 7 and 8 December 2006 - The impact on our practice and research.

2007 • 16 citations

Clinical and angiographic outcomes with an everolimus‐eluting stent in large coronary arteries: The SPIRIT III 4.0 mm registry

2009 • 14 citations

Subject Index

2008 • 1 citations